Figure 5From: CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse modelsTotal, vascular or parenchymal-deposited (a) Aβ1–40 and (b) Aβ1–42 expressed as a percentage (mean ± s.e.m) of the area studied in Tg APPsw/CD40 def. mice versus Tg APPsw mice at 22 to 24 months of age calculated by quantitative image analysis. Post hoc comparison between groups are indicated by the marked bars (* p < 0.05).Back to article page